Show Summary Details
Page of

PAH associated with schistosomiasis 

PAH associated with schistosomiasis
Chapter:
PAH associated with schistosomiasis
Author(s):

Clive Handler

and Gerry Coghlan

DOI:
10.1093/med/9780199572564.003.023
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 13 November 2019

Introduction 106

Parasite life cycle 106

Diagnosis of schistosomiasis 106

Pathophysiology of schistosomiasis-associated PAH 107

Chronic schistosomiasis and PAH 107

Clinical features of schistosomiasis-PAH 107

Treatment 107

Schistosomiasis is the 3rd leading endemic parasitic disease in the world, following malaria and amoebiasis. Schistosomiasis is believed to affect 250 million people world wide, predominantly in tropical zones of South America, Asia, and Africa. Mortality is 11,000 deaths per year....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.